# TPF-Induction Chemotherapy of Oropharyngeal and Cavity of the Mouth Cancer

> **NCT01108042** · PHASE1,PHASE2 · COMPLETED · sponsor: **Orlando Guntinas-Lichius, Prof. Dr. med.** · enrollment: 71 (actual)

## Conditions studied

- Oropharynx Cancer
- Squamous Cell Carcinoma of the Oral Cavity

## Interventions

- **DRUG:** Taxotere, Cisplatin, 5-Fluorouracil (5-FU)

## Key facts

- **NCT ID:** NCT01108042
- **Lead sponsor:** Orlando Guntinas-Lichius, Prof. Dr. med.
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11
- **Primary completion:** 2016-01
- **Final completion:** 2016-02
- **Target enrollment:** 71 (ACTUAL)
- **Last updated:** 2016-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01108042

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01108042, "TPF-Induction Chemotherapy of Oropharyngeal and Cavity of the Mouth Cancer". Retrieved via AI Analytics 2026-08-12 from https://api.ai-analytics.org/clinical/NCT01108042. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*